146 related articles for article (PubMed ID: 18181994)
1. Angiomatous nodules acquired after allogeneic stem cell transplantation.
Braun-Falco M; Menzel H
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):123-4. PubMed ID: 18181994
[No Abstract] [Full Text] [Related]
2. Adoptive transfer of vitiligo after allogeneic peripheral blood stem cell transplant.
Campbell-Fontaine A; Coad JE; Kovach R; Ericson SG
Bone Marrow Transplant; 2005 Oct; 36(8):745-6. PubMed ID: 16113666
[No Abstract] [Full Text] [Related]
3. Wernicke's encephalopathy after allogeneic stem cell transplantation.
Baek JH; Sohn SK; Kim DH; Kim JG; Lee HW; Park SP; Lee KB
Bone Marrow Transplant; 2005 Apr; 35(8):829-30. PubMed ID: 15750604
[No Abstract] [Full Text] [Related]
4. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
Valcárcel D; Martino R; Piñana JL; Sierra J
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of acute leukemia with allogeneic stem cell transplantation].
Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
Lodewyck T; Cornelissen JJ
Blood Rev; 2008 Nov; 22(6):293-302. PubMed ID: 18455284
[TBL] [Abstract][Full Text] [Related]
8. Cerebral tuberculosis post stem cell transplant.
Bloor AJ; Mackinnon S
Eur J Haematol; 2006 Nov; 77(5):456. PubMed ID: 16856918
[No Abstract] [Full Text] [Related]
9. Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia.
Wheatley K; Gray R
Int J Epidemiol; 2004 Feb; 33(1):15-7. PubMed ID: 15075139
[No Abstract] [Full Text] [Related]
10. Skin Lesions and Recurrent Fever in Acute Myeloid Leukemia Patient Treated With Allogeneic Stem Cell Transplant.
Yun S; Vincelette ND
JAMA Oncol; 2016 Dec; 2(12):1649-1650. PubMed ID: 27583691
[No Abstract] [Full Text] [Related]
11. A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.
Lam W; Viswabandya A; Hussain S; Messner HA; Michelis FV; Kim DD; Lipton JH; Deotare U
Bone Marrow Transplant; 2016 Oct; 51(10):1385-1386. PubMed ID: 27183093
[No Abstract] [Full Text] [Related]
12. Heterogeneous loss of the Y chromosome in leukocyte lineages of donor origin after stem cell transplantation.
Buño I; Kwon M; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
Bone Marrow Transplant; 2006 Sep; 38(6):463-5. PubMed ID: 16892070
[No Abstract] [Full Text] [Related]
13. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic stem cell transplantation in acute myelogenous leukemia].
Brinch L; Tjønnfjord G; Gedde-Dahl T; Heldal D; Holme PA; Dybedal I
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1681-2; author reply 1682. PubMed ID: 18704137
[No Abstract] [Full Text] [Related]
15. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
16. Peptide vaccines for patients with acute myeloid leukemia.
Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
[TBL] [Abstract][Full Text] [Related]
17. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
Petersen FB; Ford CD
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
[TBL] [Abstract][Full Text] [Related]
18. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
Craddock CF
Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
[TBL] [Abstract][Full Text] [Related]
19. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
